Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1066 studies found for:    Open Studies | "Neurodegenerative Diseases"
Show Display Options
Rank Status Study
21 Recruiting A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers
Conditions: Amyotrophic Lateral Sclerosis;   Nervous System Diseases;   Sclerosis;   Motor Neuron Disease;   Spinal Cord Diseases;   Central Nervous System Diseases;   Neurodegenerative Diseases;   Neuromuscular Diseases;   ALS
Intervention:
22 Recruiting Electrical Impedance Myography: Exploratory Studies in Healthy People and People With Neuromuscular Disorders
Conditions: Neuromuscular Disease;   Motor Neuron Disease;   Inherited Neuromuscular Conditions;   Inherited Neuropathies
Intervention:
23 Recruiting The Effects of Cannabis on Dystonia and Spasticity on Pediatric Patients
Conditions: Spasticity;   Dystonia
Interventions: Drug: Avidekel oil;   Drug: Enriched Avidekel oil
24 Not yet recruiting Deep Phenotyping in Patients With ALS
Conditions: ALS;   Motor Neuron Disease
Intervention:
25 Recruiting F 18 T807 Tau PET Imaging in Familial Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: Drug: F 18 T807
26 Recruiting F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E)
Conditions: Alzheimer Disease;   Progressive Posterior Cortical Dysfunction (PPCD)
Intervention: Drug: F 18 T807
27 Recruiting Use of Dalfampridin in Primary Lateral Sclerosis
Condition: Motor Neuron Disease, Upper
Intervention: Drug: dalfampridine
28 Recruiting Therapeutic Antibodies Against Prion Diseases From PRNP Mutation Carriers
Condition: Prion Diseases
Intervention: Other: blood draw
29 Recruiting Non-Invasive Measurement of Gastrointestinal (GI) Motility in Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention:
30 Recruiting Resveratrol and Huntington Disease
Condition: Huntington Disease
Interventions: Dietary Supplement: Resveratrol;   Other: Placebo
31 Recruiting Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression
Condition: Parkinson Disease
Intervention: Drug: Datscan and AV-133
32 Not yet recruiting F 18 T807 Tau PET Imaging of Frontotemporal Dementia (FTD)
Condition: Alzheimer Disease
Intervention: Drug: F 18 T807
33 Recruiting F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's Network (DIAN Project)
Condition: Alzheimer Disease
Intervention: Drug: F 18 T807
34 Recruiting Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: NP001;   Drug: Placebo
35 Recruiting A Study of LY3314814 in Participants With Mild Alzheimer's Disease Dementia
Condition: Alzheimer's Disease
Interventions: Drug: LY3314814;   Drug: Placebo
36 Recruiting Slowing Down Disease Progression in Premanifest SCA: a Piloting Interventional Exergame Trial
Condition: Spinocerebellar Ataxia
Intervention: Other: Motor training
37 Not yet recruiting A Study of LY3314814 in Early Alzheimer's Disease Dementia
Condition: Alzheimer's Disease
Intervention: Drug: LY3314814
38 Recruiting Physiological Effects of Nutritional Support in Patients With Parkinson's Disease
Conditions: Parkinson Disease;   Idiopathic Parkinson Disease
Intervention: Dietary Supplement: Intravenous and Oral n—acetyl cysteine
39 Recruiting F 18 T807 Tau PET Imaging of Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: F 18 T807
40 Recruiting A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ABBV-8E12;   Drug: placebo for ABBV-8E12

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.